More answers like this
Grok 4.5Nov 1, 2026x-ai/grok-4.5-20260708

Is the US prepared to deal with another pandemic or widespread health crisis?

No, the US is not fully prepared for another pandemic or widespread health crisis, though it has made meaningful improvements in specific areas since COVID-19. Assessments from bipartisan commissions, government watchdogs, public health organizations, and experts consistently describe progress as incomplete, uneven, and fragile, with significant remaining vulnerabilities in funding, coordination, infrastructure, public trust, and sustained political commitment.[1]

Key Improvements Post-COVID

The Biden-Harris administration and prior efforts rebuilt key capacities:

•Strategic National Stockpile (SNS): Dramatically expanded. It now holds roughly 70 times more N95 respirators, 34 times more gloves, 50 times more isolation gowns, and 10 times more ventilators than pre-pandemic levels. It has supported responses to COVID-19, mpox, H5N1 bird flu, and other threats with PPE, antivirals, vaccines, and more.[2]
•Surveillance and data systems: Electronic case reporting expanded from fewer than 200 healthcare facilities in 2020 to over 45,000–48,000 by 2024. Syndromic surveillance covers most hospital EDs, with advances in wastewater monitoring and forecasting.[3]
•Coordination and policy: Creation of the permanent Office of Pandemic Preparedness and Response Policy (OPPR) in 2023 in the Executive Office of the President. Updated biodefense strategies, dual-use research oversight, and investments in mRNA platforms and medical countermeasures (via BARDA and Project BioShield). Global efforts include billions for health security and vaccine sharing.[2]
•Other advances: Faster diagnostic development partnerships (“warm bases” with labs), nurse licensure compact expansion (facilitating surge staffing), and some state-level accreditation gains.[4]

These steps address early COVID failures in testing, PPE shortages, and coordination. The US has historically ranked high on metrics like the Global Health Security Index (top in some editions), reflecting strong lab capacity, detection potential, and resources on paper.[5]

Persistent Gaps and Criticisms

Despite gains, multiple independent reviews conclude the nation remains underprepared:

•Bipartisan Commission on Biodefense (2024 National Blueprint): States the biological threat is “real and growing” and the US is “dangerously vulnerable.” It calls for “immediate action,” notes fragmented leadership, incomplete implementation of prior recommendations, and risks of sliding backward as COVID urgency fades. It urges stronger White House-level leadership, better intelligence/attribution, science/tech investment, preparedness, detection, and response.[1]
•Trust for America’s Health (TFAH) *Ready or Not 2025*: Only 21 states + DC in the high-performance tier for public health emergency preparedness; 16 medium and 13 low. Strengths include nurse compact membership and accreditations. Weaknesses: public health funding cuts in 14 states (FY 2024), low flu vaccination (~47% vs. 70% goal), limited paid time off access, high avoidable mortality (especially disparities by race/ethnicity and region), and variable lab surge capacity. It highlights H5N1 risks and calls for stable funding, PAHPA reauthorization, better countermeasures stockpiling, and equity focus.[4]
•GAO oversight: Hundreds of COVID-related recommendations (over 400–480 across reports). Roughly half remained open as of mid-to-late 2025 (around 200 open). Open items cover HHS leadership/coordination of emergencies (a High Risk List area), workforce, IT systems/duplication/privacy, isolation/quarantine planning, fraud prevention in relief programs, and more. Implementation has yielded billions in savings but leaves preparedness holes.[6]
•Funding and sustainment shortfalls: Gaps between authorized needs (e.g., PHEMCE estimates) and appropriations. Public health infrastructure was chronically underfunded pre-COVID; emergency funds have expired, leading to workforce losses and cuts. Supply chains remain vulnerable; healthcare surge capacity, staffing, and equity issues persist.[7]
•Leadership, trust, and politics: Ambiguities in federal-state authorities, turf issues, and politicization hampered COVID response and linger. Public trust in institutions like the CDC is uneven. Experts note incomplete lesson-learning (e.g., NEJM on H5N1 response patterns). Some recent analyses (including post-2024 election contexts) flag risks from funding disruptions, potential WHO disengagement, or shifts away from certain research/vaccine platforms.[8]
•Broader system issues: Hospital surge limitations, antimicrobial resistance, inequities in access/outcomes, and concurrent threats (climate disasters as multipliers). State/local variations mean national readiness depends on the weakest links. Public polls show low confidence (e.g., only about 35% of Americans view the US as adequately prepared).[9]

Current Context and Outlook

Threats like H5N1 (widespread in animals with limited human cases), mpox, and others continue to test systems. Responses have used improved tools (e.g., SNS PPE/antivirals, stockpiled vaccines), but gaps in testing scale-up, agricultural-public health coordination, and rapid countermeasures adaptation are noted.[10]

Global efforts (WHO Pandemic Agreement, IHR amendments, Pandemic Fund) have advanced, but national capacity is foundational—and uneven worldwide.[11]

Bottom line: The US is better positioned than in early 2020 in stockpiles, surveillance, and some institutional structures, with proven rapid vaccine/therapeutic development capacity. However, it is not robustly prepared for a severe, novel, or concurrent crisis due to incomplete reforms, funding instability, coordination challenges, workforce/public health infrastructure weaknesses, and eroded trust. Experts emphasize that preparedness requires sustained (not crisis-only) investment, bipartisan leadership, resilient supply chains/health systems, equity focus, and full implementation of recommendations. Without these, another major event risks repeating or exceeding COVID-scale impacts. Ongoing monitoring of H5N1 and other pathogens, plus reauthorization of key laws like PAHPA with adequate funding, will be critical tests.

Citations (11)

  1. 1biodefensecommission.orgNonprofits and think tanks
    https://biodefensecommission.org/reports/the-national-blueprint-for-biodefense/

    Backs: “Assessments from bipartisan commissions, government watchdogs, public health organizations, and experts consistently describe progress as incomplete, uneven, and fragile, with significant remaining vulnerabilities in funding, coordination, infrastructure, public trust, and sustained political commitment.”

  2. 2archives.govGovernment
    https://bidenwhitehouse.archives.gov/briefing-room/statements-releases/2025/01/14/report-the-biden-harris-administration-roadmap-for-pandemic-preparedness-and-response/

    Backs: “It has supported responses to COVID-19, mpox, H5N1 bird flu, and other threats with PPE, antivirals, vaccines, and more.”

  3. 3cdc.govGovernment
    https://www.cdc.gov/washington/testimony/2024/t20241114.htm

    Backs: “Syndromic surveillance covers most hospital EDs, with advances in wastewater monitoring and forecasting.”

  4. 4tfah.orgNonprofits and think tanks
    https://www.tfah.org/article/new-report-measures-states-preparedness-for-public-health-emergencies-including-infectious-disease-outbreaks-and-extreme-weather-events/

    Backs: “Faster diagnostic development partnerships (“warm bases” with labs), nurse licensure compact expansion (facilitating surge staffing), and some state-level accreditation gains.”

  5. 5bit.lyCompanies
    https://bit.ly/2UrPEMn

    Backs: “The US has historically ranked high on metrics like the Global Health Security Index (top in some editions), reflecting strong lab capacity, detection potential, and resources on paper.”

  6. 6gao.govGovernment
    https://www.gao.gov/products/gao-25-107588

    Backs: “Implementation has yielded billions in savings but leaves preparedness holes.”

  7. 7center-forward.orgNonprofits and think tanks
    https://center-forward.org/basic/pandemic-preparedness-strengthening-the-u-s-response-framework-2/

    Backs: “Supply chains remain vulnerable; healthcare surge capacity, staffing, and equity issues persist.”

  8. 8nejm.orgAcademic
    https://www.nejm.org/doi/full/10.1056/NEJMp2406427

    Backs: “Some recent analyses (including post-2024 election contexts) flag risks from funding disruptions, potential WHO disengagement, or shifts away from certain research/vaccine platforms.”

  9. 9ipsos.comCompanies
    https://www.ipsos.com/en-us/axios-ipsos-american-health-index

    Backs: “Public polls show low confidence (e.g., only about 35% of Americans view the US as adequately prepared).”

  10. 10apnews.comNews and mediaquality 1.00
    https://apnews.com/article/pandemic-preparedness-trump-biden-192518a8e1414cf40bafefdc2bf1f5ca

    Backs: “Responses have used improved tools (e.g., SNS PPE/antivirals, stockpiled vaccines), but gaps in testing scale-up, agricultural-public health coordination, and rapid countermeasures adaptation are noted.”

  11. 11who.intGovernment
    https://www.who.int/news/item/02-02-2026-six-years-after-covid-19-s-global-alarm-is-the-world-better-prepared-for-the-next-pandemic

    Backs: “Global efforts (WHO Pandemic Agreement, IHR amendments, Pandemic Fund) have advanced, but national capacity is foundational—and uneven worldwide.”